These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8790757)

  • 1. Vestibular training for acute unilateral vestibular disturbances: its efficacy in comparison with antivertigo drug.
    Fujino A; Tokumasu K; Okamoto M; Naganuma H; Hoshino I; Arai M; Yoneda S
    Acta Otolaryngol Suppl; 1996; 524():21-6. PubMed ID: 8790757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vestibular training for benign paroxysmal positional vertigo. Its efficacy in comparison with antivertigo drugs.
    Fujino A; Tokumasu K; Yosio S; Naganuma H; Yoneda S; Nakamura K
    Arch Otolaryngol Head Neck Surg; 1994 May; 120(5):497-504. PubMed ID: 8172700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.
    Mira E; Guidetti G; Ghilardi L; Fattori B; Malannino N; Maiolino L; Mora R; Ottoboni S; Pagnini P; Leprini M; Pallestrini E; Passali D; Nuti D; Russolo M; Tirelli G; Simoncelli C; Brizi S; Vicini C; Frasconi P
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):73-7. PubMed ID: 12582782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Benign Paroxysmal Positional Vertigo: A Comparative Study between Epleys Manouvre and Betahistine.
    Kaur J; Shamanna K
    Int Tinnitus J; 2017 Jun; 21(1):30-34. PubMed ID: 28723599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine in the Treatment of Peripheral Vestibular Vertigo: Results of a Real-Life Study in Primary Care.
    Sanchez-Vanegas G; Castro-Moreno C; Buitrago D
    Ear Nose Throat J; 2020 Jul; 99(6):356-360. PubMed ID: 31111729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.
    Cavaliere M; Mottola G; Iemma M
    Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):107-12. PubMed ID: 16116833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute vestibular vertigo.
    Aantaa E
    Acta Otolaryngol Suppl; 1991; 479():44-7. PubMed ID: 2068940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of betahistine in the treatment of peripheral vertigo.
    Ramos Alcocer R; Ledezma Rodríguez JG; Navas Romero A; Cardenas Nuñez JL; Rodríguez Montoya V; Deschamps JJ; Liviac Ticse JA
    Acta Otolaryngol; 2015; 135(12):1205-11. PubMed ID: 26245698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study.
    Parfenov VA; Golyk VA; Matsnev EI; Morozova SV; Melnikov OA; Antonenko LM; Sigaleva EE; Situkho MI; Asaulenko OI; Popovych VI; Zamergrad MV
    PLoS One; 2017; 12(3):e0174114. PubMed ID: 28358888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.
    Albera R; Ciuffolotti R; Di Cicco M; De Benedittis G; Grazioli I; Melzi G; Mira E; Pallestrini E; Passali D; Serra A; Vicini C
    Acta Otolaryngol; 2003 Jun; 123(5):588-93. PubMed ID: 12875580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study.
    Oosterveld WJ
    J Laryngol Otol; 1984 Jan; 98(1):37-41. PubMed ID: 6363584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient baseline characteristics in an open-label multinational study of betahistine in recurrent peripheral vestibular vertigo: the OSVaLD study.
    Pérez-Garrigues H; Kuessner D; Benecke H
    Curr Med Res Opin; 2007 Nov; 23(11):2753-61. PubMed ID: 17910803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betahistine in Ménière's disease.
    Wilmot TJ; Menon GN
    J Laryngol Otol; 1976 Sep; 90(9):833-40. PubMed ID: 787460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral, central and functional vertigo syndromes].
    Strupp M; Dieterich M; Zwergal A; Brandt T
    Nervenarzt; 2015 Dec; 86(12):1573-84; quiz 1585-6. PubMed ID: 26643594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
    Popova NF; Chugunova MA; Kunel'skaia NL; Shagaev AS; Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):77-81. PubMed ID: 21916160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A use of betaserc in ataxic syndromes].
    Prokopenko SV; Rudnev VA; Afanas'eva EV; Abramov VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):41-5. PubMed ID: 15554141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine in the treatment of vertigo.
    Fischer AJ
    Acta Otolaryngol Suppl; 1991; 479():24-8. PubMed ID: 2068937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betahistine hydrochloride in Méniére's disease.
    Frew IJ; Menon GN
    Postgrad Med J; 1976 Aug; 52(610):501-3. PubMed ID: 790351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification.
    Lacour M
    J Vestib Res; 2013; 23(3):139-51. PubMed ID: 24177346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.